Investigating Ovulation Inhibition for Use as a Contraceptive

NCT07365904 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Contraception

Interventions

DRUG: MR-130A-01 contraceptive transdermal patch, containing norelgestromin (NGMN)

Sponsor

Mylan Pharmaceuticals Inc